"Please Note: Due to the COVID-19 virus some locations have moved. Please contact your doctor's office to confirm the address. BMC is restricting all visitors unless pre-approved by each patient's care team under extenuating circumstances. Medical Clinic"

During the past decade, Amyloidosis Center, Boston Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amyloidosis Center, Boston Medical Center" #1 collaborator was "Corino Therapeutics, Inc." with 1 trials as a collaborator, "Food and Drug Administration (FDA)" with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Amyloidosis Center, Boston Medical Center" are "Amyloidosis, Leptomeningeal, Transthyretin-Related" (1 trials), "Familial Amyloid Polyneuropathy" (1 trials), "Familial Amyloidosis" (1 trials) and "Transthyretin Amyloidosis" (1 trials). Many other conditions were trialed in "Amyloidosis Center, Boston Medical Center" in a lesser frequency.

Most popular intervention types in "Amyloidosis Center, Boston Medical Center" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tolcapone" (1 trials), "diflunisal" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Amyloidosis Center, Boston Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Amyloidosis Center, Boston Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Amyloidosis Center, Boston Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Amyloidosis Center, Boston Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".